Role of advanced respiratory support in acute respiratory failure in clinically frail patients with COVID-19
Background: The main aim of this study was to assess the efficacy of advanced respiratory support (ARS) for acute respiratory failure in do-not-attempt cardiopulmonary resuscitation order (DNACPR) COVID-19 patients. Methods: In this single-center study, the impact of different types of ARS modality, PaO2/FiO2 (PF) ratio, clinical frailty score (CFS) and 4C score on mortality was evaluated. Results: There was no significant difference in age, type of ARS modality, PF ratio and 4C scores between those who died and those who survived. Overall survival rates/hospital discharge of patients still requiring ARS at 5 and 7 days post admission were 20 and 17%, respectively. Conclusion: Our study showed that ARS can be a useful tool in frail, elderly and high-risk COVID-19 patients irrespective of high 4C mortality score.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Future microbiology - 17(2022) vom: 22. Jan., Seite 89-97 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nadeem, Iftikhar [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 25.01.2022 Date Revised 25.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/fmb-2021-0226 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM334519411 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM334519411 | ||
| 003 | DE-627 | ||
| 005 | 20231225223853.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/fmb-2021-0226 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1115.xml |
| 035 | |a (DE-627)NLM334519411 | ||
| 035 | |a (NLM)34915735 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nadeem, Iftikhar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Role of advanced respiratory support in acute respiratory failure in clinically frail patients with COVID-19 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.01.2022 | ||
| 500 | |a Date Revised 25.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Background: The main aim of this study was to assess the efficacy of advanced respiratory support (ARS) for acute respiratory failure in do-not-attempt cardiopulmonary resuscitation order (DNACPR) COVID-19 patients. Methods: In this single-center study, the impact of different types of ARS modality, PaO2/FiO2 (PF) ratio, clinical frailty score (CFS) and 4C score on mortality was evaluated. Results: There was no significant difference in age, type of ARS modality, PF ratio and 4C scores between those who died and those who survived. Overall survival rates/hospital discharge of patients still requiring ARS at 5 and 7 days post admission were 20 and 17%, respectively. Conclusion: Our study showed that ARS can be a useful tool in frail, elderly and high-risk COVID-19 patients irrespective of high 4C mortality score | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a ISARIC 4C mortality score | |
| 650 | 4 | |a PaO2/FiO2 Ratio | |
| 650 | 4 | |a acute respiratory support | |
| 650 | 4 | |a clinical frailty score (CFS) | |
| 650 | 4 | |a invasive mechanical ventilation | |
| 650 | 4 | |a noninvasive mechanical ventilation (CPAP & HFNO) | |
| 700 | 1 | |a Jordon, Louise |e verfasserin |4 aut | |
| 700 | 1 | |a Rasool, Masood Ur |e verfasserin |4 aut | |
| 700 | 1 | |a Mahdi, Noor |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Ritesh |e verfasserin |4 aut | |
| 700 | 1 | |a Rehman, Zahra |e verfasserin |4 aut | |
| 700 | 1 | |a Tilley, Craig J |e verfasserin |4 aut | |
| 700 | 1 | |a Kang, Simran |e verfasserin |4 aut | |
| 700 | 1 | |a Rai, Amrita |e verfasserin |4 aut | |
| 700 | 1 | |a Lok, She |e verfasserin |4 aut | |
| 700 | 1 | |a McMillan, Alison |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future microbiology |d 2006 |g 17(2022) vom: 22. Jan., Seite 89-97 |w (DE-627)NLM171766504 |x 1746-0921 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2022 |g day:22 |g month:01 |g pages:89-97 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/fmb-2021-0226 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2022 |b 22 |c 01 |h 89-97 | ||